Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience. (Record no. 25989855)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 01954 a2200589 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517093548.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201801s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1949-2553 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.18632/oncotarget.9048 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Hou, Ming-Mo |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180117 |
| 245 00 - TITLE STATEMENT | |
| Title | Continuous anti-angiogenic therapy after tumor progression in patients with recurrent high-grade epithelial ovarian cancer: phase I trial experience. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Oncotarget |
| Date of publication, distribution, etc. | Jun 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 35132-43 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Angiogenesis Inhibitors |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents |
| General subdivision | therapeutic use |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoma, Ovarian Epithelial |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Clinical Trials, Phase I as Topic |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease Progression |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Kaplan-Meier Estimate |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Recurrence, Local |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasms, Glandular and Epithelial |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Ovarian Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Proportional Hazards Models |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Retrospective Studies |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wang, Zhijie |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Janku, Filip |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Piha-Paul, Sarina |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Naing, Aung |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hong, David |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Westin, Shannon |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Coleman, Robert L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sood, Anil K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Tsimberidou, Apostolia M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Subbiah, Vivek |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wheler, Jennifer |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zinner, Ralph |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lu, Karen |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Meric-Bernstam, Funda |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Fu, Siqing |
| 773 0# - HOST ITEM ENTRY | |
| Title | Oncotarget |
| Related parts | vol. 7 |
| -- | no. 23 |
| -- | p. 35132-43 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.18632/oncotarget.9048">https://doi.org/10.18632/oncotarget.9048</a> |
| Public note | Available from publisher's website |
No items available.